Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women - PubMed (original) (raw)

Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women

N al-Muhtaseb et al. Diabet Med. 1991 Oct.

Abstract

Plasma lipid and apolipoprotein levels of Type 1 and Type 2 young Kuwaiti diabetic women on insulin therapy were investigated to elucidate the relationship between coronary artery disease risk factors and lipid levels. Forty Type 1 and 52 Type 2 diabetic women and 45 and 62 corresponding control subjects (matched for age and body mass index) were investigated. In comparison with control subjects, both groups of diabetic patients showed marked increases in total-cholesterol, LDL-cholesterol, triglycerides, very low density triglycerides, apolipoprotein B, glucose, fructosamine, and glycosylated haemoglobin HbA1c (all p less than 0.001). However, apolipoprotein CIII was significantly elevated in Type 2 diabetic patients (p less than 0.001) but not in Type 1 patients. Concentrations of apolipoproteins CII and AII in both diabetic groups were not significantly different from those in control subjects. Levels of HDL-, HDL2- and HDL3-cholesterol and plasma apolipoprotein AI were markedly decreased in both the diabetic groups compared with their control groups (all p less than 0.001 except HDL3-cholesterol in Type 1 diabetic vs control, p less than 0.05). In Type 2 diabetic patients, HbA1c correlated positively with triglycerides (r = 0.70, p less than 0.001), cholesterol (r = 0.60, p less than 0.001), apolipoprotein B (r = 0.77, p less than 0.001), and apolipoprotein CIII (r = 0.55, p less than 0.001) and negatively with apolipoprotein AI (r = -0.49, p less than 0.001). In Type 1 diabetic patients HbA1c correlated positively only with apolipoprotein CIII (r = 0.50, p less than 0.001).

PubMed Disclaimer

Cited by

Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study.
Cieluch A, Uruska A, Nowicki M, Wysocka E, Niedźwiecki P, Grzelka-Woźniak A, Flotyńska J, Zozulińska-Ziółkiewicz D. Cieluch A, et al. Arch Med Sci. 2020 Oct 29;18(3):596-603. doi: 10.5114/aoms.2020.100255. eCollection 2022. Arch Med Sci. 2020. PMID: 35591821 Free PMC article.
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.
Ebara T, Conde K, Kako Y, Liu Y, Xu Y, Ramakrishnan R, Goldberg IJ, Shachter NS. Ebara T, et al. J Clin Invest. 2000 Jun;105(12):1807-18. doi: 10.1172/JCI8283. J Clin Invest. 2000. PMID: 10862796 Free PMC article.

Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women - PubMed (original) (raw)